Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 7/20 | 0.59 |
| ▸ | NPY1R | P25929 | 3/20 | 0.59 |
| ▸ | NPY2R | P49146 | 3/20 | 0.59 |
| ▸ | NPY4R | P50391 | 3/20 | 0.59 |
| ▸ | PRKACB | P22694 | 1/20 | 0.57 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.53 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29511721 | 0.95 | GHSR (0.55) | GHSRNPY1RNPY2RNPY4RPRKACB | |
| SCHEMBL29641082 | 0.94 | GHSR (0.61) | GHSRNPY1RNPY2RNPY4RPRKACB | |
| SCHEMBL29641066 | 0.94 | GHSR (0.61) | GHSRNPY1RNPY2RNPY4RPRKACB | |
| SCHEMBL29483769 | 0.94 | GHSR (0.60) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL29641173 | 0.94 | GHSR (0.60) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL29483770 | 0.94 | GHSR (0.60) | GHSRPRKACBUTS2RNPBWR1 | |
| SCHEMBL29641180 | 0.94 | GHSR (0.58) | GHSRNPY1RNPY2RNPY4RPRKACB | |
| SCHEMBL30118086 | 0.93 | GHSR (0.57) | GHSRNPY1RNPY2RNPY4RPRKACB | |
| SCHEMBL30773914 | 0.93 | GHSR (0.57) | GHSRNPY1RNPY2RNPY4RPRKACB | |
| SCHEMBL31193750 | 0.91 | NPY4R (0.58) | GHSRNPY1RNPY2RNPY4RPRKACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110263975-A1 | FLUORESCENT PROBES HAVING A POLYMERIC BACKBONE | GE HEALTHCARE AS (NO) | 2011-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263975-A1 | FLUORESCENT PROBES HAVING A POLYMERIC BACKBONE | CD38, ARFGAP1, ADCYAP1R1 | GHSR 3866/4885NPY1R 1692/4885NPY2R 2352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.